"Golightly M"[Author] - Search Results

Year	Number of Results
1980	1
1988	2
1990	1
1992	1
1994	1
1999	1
2000	1
2002	2
2008	1
2009	1
2012	2
2013	3
2014	3
2015	3
2016	2
2017	2
2018	1
2020	1
2022	1
2023	1

1

Effects of hydration status on cognitive performance and mood.

Masento NA, Golightly M, Field DT, Butler LT, van Reekum CM. Masento NA, et al. Among authors: golightly m. Br J Nutr. 2014 May 28;111(10):1841-52. doi: 10.1017/S0007114513004455. Epub 2014 Jan 30. Br J Nutr. 2014. PMID: 24480458 Free article. Review.

2

Adults with intellectual disabilities and third-wave therapies: A systematic review and meta-ethnography.

Patterson CW, Golightly M. Patterson CW, et al. Among authors: golightly m. J Appl Res Intellect Disabil. 2023 Jan;36(1):13-27. doi: 10.1111/jar.13045. Epub 2022 Nov 6. J Appl Res Intellect Disabil. 2023. PMID: 36336795 Review.

3

Innovative Approach to Senior Practicum Students.

Golightly M, Kennett N, Stout JA. Golightly M, et al. J Nurs Educ. 2017 Dec 1;56(12):745-747. doi: 10.3928/01484834-20171120-08. J Nurs Educ. 2017. PMID: 29206266

4

A multiplex serologic platform for diagnosis of tick-borne diseases.

Tokarz R, Mishra N, Tagliafierro T, Sameroff S, Caciula A, Chauhan L, Patel J, Sullivan E, Gucwa A, Fallon B, Golightly M, Molins C, Schriefer M, Marques A, Briese T, Lipkin WI. Tokarz R, et al. Among authors: golightly m. Sci Rep. 2018 Feb 16;8(1):3158. doi: 10.1038/s41598-018-21349-2. Sci Rep. 2018. PMID: 29453420 Free PMC article.

5

Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor.

Chen KH, Wada M, Pinz KG, Liu H, Lin KW, Jares A, Firor AE, Shuai X, Salman H, Golightly M, Lan F, Senzel L, Leung EL, Jiang X, Ma Y. Chen KH, et al. Among authors: golightly m. Leukemia. 2017 Oct;31(10):2151-2160. doi: 10.1038/leu.2017.8. Epub 2017 Jan 12. Leukemia. 2017. PMID: 28074066 Free PMC article.

6

Cell-mediated immunity in allopurinol-induced hypersensitivity.

Braden GL, Warzynski MJ, Golightly M, Ballow M. Braden GL, et al. Among authors: golightly m. Clin Immunol Immunopathol. 1994 Feb;70(2):145-51. doi: 10.1006/clin.1994.1022. Clin Immunol Immunopathol. 1994. PMID: 8299230

7

Novel anti-CD3 chimeric antigen receptor targeting of aggressive T cell malignancies.

Chen KH, Wada M, Firor AE, Pinz KG, Jares A, Liu H, Salman H, Golightly M, Lan F, Jiang X, Ma Y. Chen KH, et al. Among authors: golightly m. Oncotarget. 2016 Aug 30;7(35):56219-56232. doi: 10.18632/oncotarget.11019. Oncotarget. 2016. PMID: 27494836 Free PMC article.

8

Preclinical targeting of human T-cell malignancies using CD4-specific chimeric antigen receptor (CAR)-engineered T cells.

Pinz K, Liu H, Golightly M, Jares A, Lan F, Zieve GW, Hagag N, Schuster M, Firor AE, Jiang X, Ma Y. Pinz K, et al. Among authors: golightly m. Leukemia. 2016 Mar;30(3):701-7. doi: 10.1038/leu.2015.311. Epub 2015 Nov 3. Leukemia. 2016. PMID: 26526988

9

Lymphocyte surface markers and cytotoxicity following cryopreservation.

Callery CD, Golightly M, Sidell N, Golub SH. Callery CD, et al. Among authors: golightly m. J Immunol Methods. 1980;35(3-4):213-23. doi: 10.1016/0022-1759(80)90248-3. J Immunol Methods. 1980. PMID: 6447175

10

Prognostic analysis of invasive circulating tumor cells (iCTCs) in epithelial ovarian cancer.

Pearl ML, Zhao Q, Yang J, Dong H, Tulley S, Zhang Q, Golightly M, Zucker S, Chen WT. Pearl ML, et al. Among authors: golightly m. Gynecol Oncol. 2014 Sep;134(3):581-90. doi: 10.1016/j.ygyno.2014.06.013. Epub 2014 Jun 24. Gynecol Oncol. 2014. PMID: 24972191 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

28 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year